SCHEMBL4194381

SCHEMBL4194381

CCC(CC)n1c(CC=O)cc2cnc(Cl)nc21

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4189798 0.81 CYP1A2 (0.32) CYP1A2
SCHEMBL4195718 0.80
SCHEMBL4196172 0.77 DHFR (0.34) CYP1A2
SCHEMBL4201277 0.76 CCR9 (0.36) CYP1A2
SCHEMBL4194379 0.76 CDK4 (0.36) CYP1A2
SCHEMBL6806254 0.75 CDK4 (0.46) CYP1A2
SCHEMBL4194383 0.74 CTSS (0.35)
SCHEMBL4195717 0.73 BACE1 (0.30)
SCHEMBL4186998 0.73 CDK4 (0.43)
SCHEMBL4200625 0.71 KDM4E (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029145-A2 PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES Novartis Ag (CH) 2009-03-04 EP disclosed
WO-2007140222-A2 PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2007-12-06 WO disclosed